Oncology Brothers: Practice-Changing Cancer Discussions
A podcast by Oncology Brothers
109 Episodes
-
Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab
Published: 1/22/2025 -
ASH Lymphoma 2024 Highlights - POLARIX Update, inMIND, TRIANGLE, ENRICH with Dr. Pallawi Torka
Published: 1/21/2025 -
SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney
Published: 1/17/2025 -
SABCS 2024 Highlights - EUROPA, TAILORx, PADMA, EMBER-3 with Dr. Jame Abraham
Published: 1/15/2025 -
Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options & Strategies
Published: 1/13/2025 -
SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA
Published: 1/9/2025 -
Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski
Published: 1/7/2025 -
FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant
Published: 1/2/2025 -
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL, Role of CAR-T Cell Therapy
Published: 12/26/2024 -
CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy
Published: 12/21/2024 -
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
Published: 12/19/2024 -
2nd line treatment in advanced HCC and when to switch
Published: 12/13/2024 -
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
Published: 12/2/2024 -
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
Published: 11/28/2024 -
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
Published: 11/25/2024 -
How to Approach and Treat Pancreatic Cancer
Published: 11/21/2024 -
Understanding the Impact of Nutrition & Exercise on Cancer Outcomes
Published: 11/18/2024 -
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
Published: 11/14/2024 -
Palliative Care Management in Cancer
Published: 11/8/2024 -
How to Approach to Ovarian Cancer from Community Oncology Perspective
Published: 10/31/2024
The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at [email protected]
